Daily Supplementation of D-ribose Shows No Therapeutic Benefits in the MHC-I Transgenic Mouse Model of Inflammatory Myositis

PLoS ONE

Volumn 8, Issue 6, 2013, Pages

  Coley, William ^a   Rayavarapu, Sree ^a   van der Meulen, Jack H ^a   Duba, Ayyappa S ^a   Nagaraju, Kanneboyina ^a,b  

^a CHILDREN'S NATIONAL MEDICAL CENTER   (United States)

^b GEORGE WASHINGTON UNIVERSITY SCHOOL OF MEDICINE AND HEALTH SCIENCES   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

MAJOR HISTOCOMPATIBILITY ANTIGEN CLASS 1; MUSCLE ENZYME; RIBOKINASE; RIBOSE; UNCLASSIFIED DRUG;

ANIMAL BEHAVIOR; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BODY WEIGHT; CONTROLLED STUDY; DISEASE COURSE; EXTENSOR DIGITORUM LONGUS MUSCLE; FEMALE; FUNCTIONAL ASSESSMENT; GENE EXPRESSION; GRIP STRENGTH; HISTOLOGY; MOLECULAR MECHANICS; MOUSE; MUSCLE FUNCTION; MUSCLE STRENGTH; MYOSITIS; NONHUMAN; OPEN FIELD BEHAVIOR; SKELETAL MUSCLE; SOLEUS MUSCLE; TRANSGENIC MOUSE; TREATMENT DURATION;

ADENOSINE MONOPHOSPHATE; AMP DEAMINASE; ANIMALS; BEHAVIOR, ANIMAL; BODY WEIGHT; DIETARY SUPPLEMENTS; DISEASE MODELS, ANIMAL; FEMALE; HISTOCOMPATIBILITY ANTIGENS CLASS I; MALE; METABOLIC NETWORKS AND PATHWAYS; MICE; MICE, TRANSGENIC; MUSCLE CONTRACTION; MUSCLE, SKELETAL; MYOSITIS; RIBOSE;

MUS; MUS MUSCULUS;

EID: 84878967328     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0065970     Document Type: Article

References (25)

1. Englund P, Lindroos E, Nennesmo I, Klareskog L, Lundberg IE, (2001) Skeletal muscle fibers express major histocompatibility complex class II antigens independently of inflammatory infiltrates in inflammatory myopathies. Am J Pathol 159: 1263-1273.
2. Sabina RL, Swain JL, Olanow CW, Bradley WG, Fishbein WN, et al. (1984) Myoadenylate deaminase deficiency. Functional and metabolic abnormalities associated with disruption of the purine nucleotide cycle. J Clin Invest 73: 720-730.
3. Li CK, Varsani H, Holton JL, Gao B, Woo P, et al. (2004) MHC Class I overexpression on muscles in early juvenile dermatomyositis. J Rheumatol 31: 605-609.
4. Fishbein WN, (1985) Myoadenylate deaminase deficiency: inherited and acquired forms. Biochem Med 33: 158-169.
5. Sabina RL, Fishbein WN, Pezeshkpour G, Clarke PR, Holmes EW, (1992) Molecular analysis of the myoadenylate deaminase deficiencies. Neurology 42: 170-179.
6. Coley W, Rayavarapu S, Pandey GS, Sabina RL, Van der Meulen JH, et al. (2012) The molecular basis of skeletal muscle weakness in a mouse model of inflammatory myopathy. Arthritis Rheum 64: 3750-3759.
7. Sabina RL, (2000) Myoadenylate deaminase deficiency. A common inherited defect with heterogeneous clinical presentation. Neurol Clin 18: 185-194.
8. Sabina RL, Sulaiman AR, Wortmann RL, (1991) Molecular analysis of acquired myoadenylate deaminase deficiency in polymyositis (idiopathic inflammatory myopathy). Adv Exp Med Biol 309B: 203-205.
9. Lecky BR, (1983) Failure of D-ribose in myoadenylate deaminase deficiency. Lancet 1: 193.
10. Zollner N, Reiter S, Gross M, Pongratz D, Reimers CD, et al. (1986) Myoadenylate deaminase deficiency: successful symptomatic therapy by high dose oral administration of ribose. Klin Wochenschr 64: 1281-1290.
11. Wagner DR, Gresser U, Zollner N, (1991) Effects of oral ribose on muscle metabolism during bicycle ergometer in AMPD-deficient patients. Ann Nutr Metab 35: 297-302.
12. Nagaraju K, Raben N, Loeffler L, Parker T, Rochon PJ, et al. (2000) Conditional up-regulation of MHC class I in skeletal muscle leads to self-sustaining autoimmune myositis and myositis-specific autoantibodies. Proc Natl Acad Sci U S A 97: 9209-9214.
13. Vattemi G, Engel WK, McFerrin J, Askanas V, (2004) Endoplasmic reticulum stress and unfolded protein response in inclusion body myositis muscle. Am J Pathol 164: 1-7.
14. Vitadello M, Doria A, Tarricone E, Ghirardello A, Gorza L, (2010) Myofiber stress-response in myositis: parallel investigations on patients and experimental animal models of muscle regeneration and systemic inflammation. Arthritis Res Ther 12: R52.
15. Steele IC, Patterson VH, Nicholls DP, (1996) A double blind, placebo controlled, crossover trial of D-ribose in McArdle's disease. J Neurol Sci 136: 174-177.
16. Kerksick C, Rasmussen C, Bowden R, Leutholtz B, Harvey T, et al. (2005) Effects of ribose supplementation prior to and during intense exercise on anaerobic capacity and metabolic markers. Int J Sport Nutr Exerc Metab 15: 653-664.
17. Berardi JM, Ziegenfuss TN, (2003) Effects of ribose supplementation on repeated sprint performance in men. J Strength Cond Res 17: 47-52.
18. Alger HM, Raben N, Pistilli E, Francia DL, Rawat R, et al. (2011) The role of TRAIL in mediating autophagy in myositis skeletal muscle: a potential nonimmune mechanism of muscle damage. Arthritis Rheum 63: 3448-3457.
19. Nagaraju K, Casciola-Rosen L, Lundberg I, Rawat R, Cutting S, et al. (2005) Activation of the endoplasmic reticulum stress response in autoimmune myositis: potential role in muscle fiber damage and dysfunction. Arthritis Rheum 52: 1824-1835.
20. Spurney CF, Gordish-Dressman H, Guerron AD, Sali A, Pandey GS, et al. (2009) Preclinical drug trials in the mdx mouse: assessment of reliable and sensitive outcome measures. Muscle Nerve 39: 591-602.
21. Rozen S, Skaletsky H, (2000) Primer3 on the WWW for general users and for biologist programmers. Methods Mol Biol 132: 365-386.
22. Salomonsson S, Grundtman C, Zhang SJ, Lanner JT, Li C, et al. (2009) Upregulation of MHC class I in transgenic mice results in reduced force-generating capacity in slow-twitch muscle. Muscle Nerve 39: 674-682.
23. Gross M, Reiter S, Zollner N, (1989) Metabolism of D-ribose administered continuously to healthy persons and to patients with myoadenylate deaminase deficiency. Klin Wochenschr 67: 1205-1213.
24. Tullson PC, Bangsbo J, Hellsten Y, Richter EA, (1995) IMP metabolism in human skeletal muscle after exhaustive exercise. J Appl Physiol 78: 146-152.
25. Hellsten Y, Richter EA, Kiens B, Bangsbo J, (1999) AMP deamination and purine exchange in human skeletal muscle during and after intense exercise. J Physiol 520 Pt 3: 909-920.